Inventor · disambiguated record
Patrick Lee
Also filed as: LEE PATRICK · LEE PATRICK S · LEE PATRICK SANG TAE
12 granted patents·4 pending applications·61 citations·filing 2007–2025
89Inventor score
Top patents by PatentIndex Score
16 records- 0194US9845325B2Tetracyclic pyridone compounds as antiviralsNOVARTIS AG·Filed 2017·Granted Dec 19, 2017·24 cites·15 claims
- 0288US11814367B2Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·4 cites·41 claims
- 0386US11976067B2APOL1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·2 cites·159 claims
- 0485US8071581B2Triazolopyridazine protein kinase modulatorsSMITH CHRISTOPHER RONALD·Filed 2007·Granted Dec 6, 2011·15 cites·2 claims
- 0583US10188649B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·3 cites·4 claims
- 0683US10093673B2Tetracyclic pyridone compounds as antiviralsNOVARTIS AG·Filed 2017·Granted Oct 9, 2018·3 cites·16 claims
- 0780US9763937B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2015·Granted Sep 19, 2017·3 cites·4 claims
- 0880US9242996B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2014·Granted Jan 26, 2016·5 cites·27 claims
- 0979US9718792B2Isoxazoline hydroxamic acid derivatives as LpxC inhibitorsNOVARTIS AG·Filed 2017·Granted Aug 1, 2017·1 cites·16 claims
- 1073US12344610B2APOL1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·20 claims
- 1168US9637482B2Isoxazoline hydroxamic acid derivatives as LpxC inhibitorsFU JIPING·Filed 2015·Granted May 2, 2017·1 cites·17 claims
- 1268US2025282781A1Apol1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1367US10660888B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2018·Granted May 26, 2020·0 cites·6 claims
- 1458US2024199546A1Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1550US2024316038A1Apol1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1645US2009156594A1Heterocyclic kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →